Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case

Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Kapil G., Sim, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567070/
https://www.ncbi.nlm.nih.gov/pubmed/28868032
http://dx.doi.org/10.1159/000477757
_version_ 1783258653482024960
author Kapoor, Kapil G.
Sim, Jennifer
author_facet Kapoor, Kapil G.
Sim, Jennifer
author_sort Kapoor, Kapil G.
collection PubMed
description Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients.
format Online
Article
Text
id pubmed-5567070
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-55670702017-09-01 Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case Kapoor, Kapil G. Sim, Jennifer Case Rep Ophthalmol Case Report Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients. S. Karger AG 2017-07-13 /pmc/articles/PMC5567070/ /pubmed/28868032 http://dx.doi.org/10.1159/000477757 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Kapoor, Kapil G.
Sim, Jennifer
Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_full Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_fullStr Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_full_unstemmed Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_short Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_sort spironolactone for secondary central serous chorioretinopathy: a challenge-rechallenge case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567070/
https://www.ncbi.nlm.nih.gov/pubmed/28868032
http://dx.doi.org/10.1159/000477757
work_keys_str_mv AT kapoorkapilg spironolactoneforsecondarycentralserouschorioretinopathyachallengerechallengecase
AT simjennifer spironolactoneforsecondarycentralserouschorioretinopathyachallengerechallengecase

Ejemplares similares